EndoMaster

EndoMaster is a medical robotics company that develops robot-assisted surgical systems for endoscopic surgeries, enabling surgeons to perform incision-less minimally invasive procedures. The company system has been tested in first-in-man clinical trials with positive results, demonstrating the feasibility of robotic-assisted endoscopic surgery for procedures that traditionally require external incisions. The technology integrates robotic manipulation with endoscopic visualization, allowing surgeons to perform complex surgical tasks through natural body openings with greater precision and control than conventional endoscopic tools. EndoMaster approach aims to reduce surgical trauma, shorten recovery times, and lower complication rates compared to traditional surgical methods. Founded in 2011 and headquartered in Singapore, the company has raised approximately $14.6 million through Series B funding from investors including Chuang Capital, NTUitive, HOYA, and Nanyang Technological University.